1. Synthesis, Characterization and Biological Evaluation of New Enamide Fluorinated‐Schiff Base Derivatives as Potential Cytotoxic and Apoptosis‐Inducing Agents
   Hany M. Abd El‐Lateef et al, 2023, ChemistrySelect CrossRef
2. JNK inhibition blocks piperlongumine-induced cell death and transcriptional activation of heme oxygenase-1 in pancreatic cancer cells
   Jiyan Mohammad et al, 2019, Apoptosis CrossRef
3. Piperlongumine induces apoptosis and G2/M phase arrest in human osteosarcoma cells by regulating ROS/PI3K/Akt pathway
   Jinfeng Zhou et al, 2020, Toxicology in Vitro CrossRef
4. Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer
   Jia-Rong Huang et al, 2020, Frontiers in Pharmacology CrossRef
5. Human serum albumin-based propulsive Piperlongumine-loaded nanoparticles: Formulation development, characterization and anti-cancer study
   Krunal Patel et al, 2022, Colloids and Surfaces A: Physicochemical and Engineering Aspects CrossRef
6. Effects of Hylomecon vernalis ethanol extracts on cell cycle and apoptosis of colon cancer cells
   Jing Sun et al, 2017, Molecular Medicine Reports CrossRef
7. Vernodalin Triggers ROS-Mediated Apoptosis in TPC-1 Human Papillary Thyroid Cancer Cells via Suppression of the MAPKs Signaling Pathway
   Xijia Yang et al, 2024, Combinatorial Chemistry & High Throughput Screening CrossRef
8. Transcriptome Analysis of Piperlongumine-Treated Human Pancreatic Cancer Cells Reveals Involvement of Oxidative Stress and Endoplasmic Reticulum Stress Pathways
   Harsharan Dhillon et al, 2016, Journal of Medicinal Food CrossRef
9. Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells
   Cinara O. D’Sousa Costa et al, 2017, Oncotarget CrossRef
10. Piperlongumine Induces Apoptosis and Cytoprotective Autophagy via the MAPK Signaling Pathway in Human Oral Cancer Cells
    Eun-Young Choi et al, 2023, Biomedicines CrossRef
11. The role of MAPK signaling pathway in the Her-2-positive meningiomas
    Zhaoyin Wang et al, 2016, Oncology Reports CrossRef
12. Discovery of piperlongumine as a potential novel lead for the development of senolytic agents
    Yingying Wang et al, 2016, Aging CrossRef
13. Caffeine and its main targets of colorectal cancer
    Wen-Qi Cui et al, 2020, World Journal of Gastrointestinal Oncology CrossRef
14. Dual-specificity Phosphatase 1 Deficiency Induces Endometrioid Adenocarcinoma Progression via Activation of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Pathway
    Yuan Yang et al, 2016, Chinese Medical Journal CrossRef
15. Piplartine (piperlongumine), oxidative stress, and use in cancer
    Daniel Pereira Bezerra, 2021, Cancer CrossRef
16. Piperlongumine, a Potent Anticancer Phytotherapeutic, Induces Cell Cycle Arrest and Apoptosis In Vitro and In Vivo through the ROS/Akt Pathway in Human Thyroid Cancer Cells
    Fang-Ping Kung et al, 2021, Cancers CrossRef
17. Piperlongumine (piplartine) as a lead compound for anticancer agents – Synthesis and properties of analogues: A mini-review
    Kamil Piska et al, 2018, European Journal of Medicinal Chemistry CrossRef
18. Natural Health Products (NHP’s) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends
    Benjamin Scaria et al, 2020, International Journal of Molecular Sciences CrossRef
19. Synthesis, in vitro cytotoxicity, and molecular docking study of novel 3,4‐dihydroisoquinolin‐1(2H)‐one based piperlongumine analogues
    Mahesh R. Kulkarni et al, 2021, Journal of Heterocyclic Chemistry CrossRef
20. Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent
    Surya Kant Tripathi et al, 2020, Pharmacological Research CrossRef
21. The promising potential of piperlongumine as an emerging therapeutics for cancer
    Dey Parama et al, 2021, Exploration of Targeted Anti-tumor Therapy CrossRef